Laboratorio Reig Jofre SA
MAD:RJF
Balance Sheet
Balance Sheet Decomposition
Laboratorio Reig Jofre SA
Current Assets | 147.6m |
Cash & Short-Term Investments | 8.6m |
Receivables | 71.3m |
Other Current Assets | 67.7m |
Non-Current Assets | 196m |
Long-Term Investments | 6.9m |
PP&E | 91.2m |
Intangibles | 89m |
Other Non-Current Assets | 8.9m |
Current Liabilities | 92.7m |
Accounts Payable | 55.1m |
Other Current Liabilities | 37.6m |
Non-Current Liabilities | 43.9m |
Long-Term Debt | 31.4m |
Other Non-Current Liabilities | 12.5m |
Balance Sheet
Laboratorio Reig Jofre SA
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
8
|
9
|
8
|
12
|
8
|
10
|
12
|
5
|
6
|
6
|
|
Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
0
|
|
Cash Equivalents |
8
|
9
|
8
|
12
|
8
|
10
|
12
|
5
|
0
|
6
|
|
Short-Term Investments |
4
|
2
|
11
|
3
|
3
|
1
|
1
|
1
|
0
|
1
|
|
Total Receivables |
31
|
34
|
36
|
35
|
36
|
45
|
47
|
50
|
55
|
62
|
|
Accounts Receivables |
30
|
34
|
36
|
35
|
34
|
41
|
43
|
44
|
49
|
56
|
|
Other Receivables |
1
|
0
|
0
|
0
|
2
|
4
|
5
|
6
|
6
|
6
|
|
Inventory |
24
|
25
|
33
|
28
|
35
|
38
|
40
|
48
|
48
|
62
|
|
Other Current Assets |
5
|
4
|
7
|
4
|
0
|
2
|
1
|
5
|
2
|
2
|
|
Total Current Assets |
72
|
75
|
95
|
81
|
82
|
96
|
101
|
109
|
112
|
133
|
|
PP&E Net |
24
|
29
|
37
|
47
|
55
|
84
|
85
|
92
|
93
|
92
|
|
PP&E Gross |
24
|
29
|
37
|
47
|
55
|
84
|
85
|
92
|
93
|
92
|
|
Accumulated Depreciation |
32
|
36
|
38
|
42
|
46
|
54
|
61
|
63
|
73
|
85
|
|
Intangible Assets |
32
|
33
|
32
|
33
|
39
|
86
|
83
|
78
|
71
|
63
|
|
Goodwill |
25
|
25
|
28
|
28
|
28
|
30
|
30
|
30
|
29
|
28
|
|
Long-Term Investments |
10
|
9
|
1
|
1
|
1
|
2
|
2
|
2
|
5
|
6
|
|
Other Long-Term Assets |
17
|
17
|
13
|
14
|
16
|
16
|
16
|
14
|
11
|
9
|
|
Other Assets |
25
|
25
|
28
|
28
|
28
|
30
|
30
|
30
|
29
|
28
|
|
Total Assets |
181
N/A
|
187
+3%
|
205
+10%
|
203
-1%
|
220
+8%
|
314
+43%
|
317
+1%
|
325
+2%
|
321
-1%
|
331
+3%
|
|
Liabilities | |||||||||||
Accounts Payable |
25
|
23
|
22
|
20
|
25
|
31
|
33
|
35
|
36
|
41
|
|
Accrued Liabilities |
1
|
4
|
4
|
4
|
5
|
5
|
7
|
6
|
7
|
7
|
|
Short-Term Debt |
10
|
7
|
13
|
5
|
4
|
7
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
1
|
1
|
1
|
1
|
2
|
8
|
14
|
18
|
24
|
30
|
|
Other Current Liabilities |
5
|
6
|
5
|
4
|
5
|
19
|
23
|
15
|
9
|
11
|
|
Total Current Liabilities |
41
|
41
|
44
|
34
|
39
|
69
|
78
|
75
|
76
|
90
|
|
Long-Term Debt |
12
|
10
|
17
|
17
|
21
|
42
|
43
|
49
|
37
|
23
|
|
Deferred Income Tax |
5
|
4
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
4
|
6
|
7
|
7
|
7
|
21
|
9
|
9
|
11
|
10
|
|
Total Liabilities |
63
N/A
|
61
-3%
|
72
+18%
|
62
-14%
|
70
+13%
|
135
+94%
|
133
-2%
|
136
+3%
|
127
-7%
|
126
0%
|
|
Equity | |||||||||||
Common Stock |
126
|
126
|
32
|
32
|
33
|
38
|
38
|
39
|
39
|
40
|
|
Retained Earnings |
4
|
4
|
103
|
111
|
119
|
124
|
129
|
134
|
142
|
150
|
|
Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
19
|
19
|
19
|
19
|
19
|
|
Treasury Stock |
5
|
5
|
2
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
|
Other Equity |
1
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
2
|
2
|
|
Total Equity |
118
N/A
|
126
+7%
|
133
+6%
|
142
+6%
|
150
+6%
|
178
+19%
|
185
+4%
|
189
+2%
|
195
+3%
|
204
+5%
|
|
Total Liabilities & Equity |
181
N/A
|
187
+3%
|
205
+10%
|
203
-1%
|
220
+8%
|
314
+43%
|
317
+1%
|
325
+2%
|
321
-1%
|
331
+3%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
67
|
68
|
68
|
68
|
68
|
78
|
79
|
79
|
79
|
79
|